Resolution of the Interdisciplinary Council of Experts «Original follitropins vs. biosimilars in Assisted Reproductive Technology programs»

Authors

Keywords:

follitropin, biosimilar, assisted reproductive technologies (ART)

Abstract

On April 24, 2023, Almaty hosted the Interdisciplinary Council of Experts on “Original follitropins vs. biosimilars in programs of assisted reproductive technologies,” initiated and organized by the Kazakhstan Association of Reproductive Medicine (KARM).
The Council involved experts in the field of reproductive medicine, clinical pharmacology, chemistry, and embryology.
The aims of the event were to study world practice, application experience, aspects of pharmacoeconomics, as well as personal experience in the use of biosimilars in assisted reproductive technology programs, discussion about differences with original drugs, risks, and scientific data in the field of using biosimilars and original follitropins.

Downloads

Published

2023-10-01

How to Cite

[1]
Vasilieva Т. and Lokshin В. 2023. Resolution of the Interdisciplinary Council of Experts «Original follitropins vs. biosimilars in Assisted Reproductive Technology programs». Reproductive Medicine (Central Asia). 3(56) (Oct. 2023), 91–92.

Issue

No. 3(56) (2023): Reproductive medicine

Section

Статьи

License

The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.